CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- FinancialsAltman Z-Score 2.19: grey zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
588.78MUSDvs all stocks (USD)
Revenue (TTM)
252.72MUSDvs all stocks (USD)
Profit Margin
-15.72%vs Medical Devices peers
Beta
0.9850xvs all stocks
52-Week Change
23.16%vs all stocks
Market Capitalization
588.78MUSDvs all stocks (USD)
Enterprise Value
654.08MUSDvs all stocks (USD)
Forward P/E
-31.76xvs Medical Devices peers
Price to Sales (TTM)
2.33xvs Medical Devices peers
Price to Book (MRQ)
1.71xvs Medical Devices peers
Enterprise to Revenue
2.59xvs Medical Devices peers
Gross Margin
74.27%vs Medical Devices peers
Profit Margin
-15.72%vs Medical Devices peers
Operating Margin
-5.77%vs Medical Devices peers
Return on Assets (TTM)
-2.80%vs Medical Devices peers
Return on Equity (TTM)
-11.36%vs Medical Devices peers
Revenue (TTM)
252.72MUSDvs all stocks (USD)
Revenue per Share (TTM)
10.65USDUpdated Sep 27, 2026Quarterly Revenue Growth
15.40%vs Medical Devices peers
Gross Profit (TTM)
186.14MUSDvs all stocks (USD)
EBITDA (TTM)
2.36MUSDvs all stocks (USD)
Net Income (TTM)
-39.73MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
15.43%vs Medical Devices peers
Operating Cash Flow (TTM)
7.41MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
3.19MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 27, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Revenue
236.35MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
63.69MUSDFY2025 · Dec 31, 2025Gross Profit
172.66MUSDFY2025 · Dec 31, 2025Operating Income
-29.00MUSDvs all stocks (USD)
Pre-tax Income
-39.19MUSDFY2025 · Dec 31, 2025Income Tax Expense
460.00KUSDFY2025 · Dec 31, 2025Net Income
-39.65MUSDFY2025 · Dec 31, 2025EBIT
-29.00MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
2.36MUSDFY2025 · Dec 31, 2025Research & Development
9.10MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
192.56MUSDFY2025 · Dec 31, 2025EPS (Basic)
-1.69USDFY2025 · Dec 31, 2025EPS (Diluted)
-1.69USDFY2025 · Dec 31, 2025Basic Shares Outstanding
23.46MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
23.46MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-39.65MUSDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00USDFY2025 · Dec 31, 2025Operating Cash Flow
-13.03MUSDFY2025 · Dec 31, 2025Free Cash Flow
-24.14MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
21.62MUSDFY2025 · Dec 31, 2025Interest Paid
6.52MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-39.65MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
21.12MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-153.00KUSDFY2025 · Dec 31, 2025Stock-based Compensation
17.78MUSDFY2025 · Dec 31, 2025Other Non-cash Items
333.00KUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-9.37MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
8.17MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-11.26MUSDFY2025 · Dec 31, 2025Capital Expenditures
-11.11MUSDFY2025 · Dec 31, 2025Net Acquisitions
-15.50MUSDFY2025 · Dec 31, 2025Purchase of Investments
-17.02MUSDFY2025 · Dec 31, 2025Sale of Investments
0.00USDFY2025 · Dec 31, 2025Net Investing Cash Flow
-43.63MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
25.00MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-158.00KUSDFY2025 · Dec 31, 2025Other Financing Charges
-867.00KUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
23.98MUSDFY2025 · Dec 31, 2025Shares Outstanding
26.11MSharesUpdated Sep 27, 2026Float Shares
18.22MSharesUpdated Sep 27, 2026Shares Short
878.31KSharesUpdated Sep 27, 2026Short Ratio
3.78daysvs all stocks
Short % of Shares Outstanding
4.95%vs all stocks
% Held by Insiders
29.69%vs all stocks
% Held by Institutions
65.89%vs all stocks
Total Cash (MRQ)
45.88MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
1.76USDUpdated Sep 27, 2026Total Debt (MRQ)
111.18MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.3236xvs Medical Devices peers
Current Ratio (MRQ)
4.78xvs Medical Devices peers
Book Value per Share (MRQ)
13.16USDUpdated Sep 27, 2026Total Assets
508.63MUSDvs all stocks (USD)
Total Current Assets
256.42MUSDFY2025 · Dec 31, 2025Total Liabilities
162.03MUSDFY2025 · Dec 31, 2025Total Non-current Assets
252.21MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
115.84MUSDFY2025 · Dec 31, 2025Total Current Liabilities
46.20MUSDFY2025 · Dec 31, 2025Cash
19.56MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
19.56MUSDFY2025 · Dec 31, 2025Other Short-term Investments
41.30MUSDFY2025 · Dec 31, 2025Accounts Receivable
53.84MUSDFY2025 · Dec 31, 2025Inventory
133.79MUSDFY2025 · Dec 31, 2025Accounts Payable
18.79MUSDFY2025 · Dec 31, 2025Short-term Debt
170.00KUSDFY2025 · Dec 31, 2025Other Current Liabilities
11.35MUSDFY2025 · Dec 31, 2025Long-term Debt
99.82MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
9.54MUSDFY2025 · Dec 31, 2025Common Stock (Book)
6.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-275.21MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
346.60MUSDvs all stocks (USD)
52-Week Low
14.42USDUpdated Sep 27, 202652-Week High
26.74USDUpdated Sep 27, 202652-Week Change
23.16%vs all stocks
Beta
0.9850xvs all stocks
50-Day MA
22.45USDUpdated Sep 27, 2026200-Day MA
18.85USDUpdated Sep 27, 2026Avg 10-Day Volume
178.77KSharesUpdated Sep 27, 2026Avg 30-Day Volume
215.83KSharesUpdated Sep 27, 2026Diluted EPS (TTM)
-1.68USDUpdated Sep 27, 2026Other Income / Expense
-4.19MUSDFY2025 · Dec 31, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.74Profit Margin: -0.16
Financial Health
Altman Z-Score 2.19: grey zoneSignificant
Altman Z-Score: 2.19
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
CytomX Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Tibet Weixinkang Medicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Aquestive Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Phathom Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shandong Wohua Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Jiangsu Sihuan Bioengineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
SS Innovations International, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Gkht Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hainan Shuangcheng Pharmaceuticals Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Altimmune, Inc.
Tier 1ProductionApproval-Gated PipelineRule